| CAS NO: | 1513857-77-6 |
| 规格: | 98% |
| 分子量: | 487.5 |
| 包装 | 价格(元) |
| 5mg | 电议 |
| 10mg | 电议 |
| 25mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
Background:
Pemigatinib is a selective FGFR inhibitor in development for the treatment of patients with cholangiocarcinoma.
[1]. Arudra K, et al. Calcinosis cutis dermatologic toxicity associated with fibroblast growth factor receptor inhibitor for the treatment of Wilms tumor. J Cutan Pathol. 2018 Oct;45(10):786-790.
m.cnreagent.com